Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
Physicians should continue efforts to vaccinate patients with cirrhosis against COVID-19
LAS VEGAS — No safety and efficacy concerns for COVID-19 messenger RNA vaccines were noted among patients with cirrhosis compared with the general population, according to a presentation at the ACG Annual Scientific Meeting.
Alcohol misuse during COVID-19 may contribute to increased need for liver transplants
Waiting list registrations and deceased donor liver transplantations for alcoholic hepatitis increased significantly during the COVID-19 pandemic compared with earlier trends, according to data published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Patient advocate sheds light on ‘urgency’ to treat chronic liver disease
LAS VEGAS – In this video exclusive, Donna Cryer, JD, founder, president and CEO Global Liver Institute, spoke on the launch of the Liver Health Annual Trends Report and its possible impact for patients with chronic liver disease.
VIDEO: Multidisciplinary approach linked to higher survival in HCC
LAS VEGAS – In this video exclusive from the ACG Scientific Annual Meeting, Amit Singal, MD, from UT Southwestern Medical Center, discussed best practices for the screening, surveillance, and treatment of hepatocellular carcinoma.
Hepatocellular carcinoma: Hope on the horizon
This month’s cover story highlights the growing burden of hepatocellular carcinoma, the most common type of primary liver cancer, in the United States. Despite being a cancer that does not typically receive much attention, HCC is projected to become the third leading cause of cancer-related death in the United States by 2040 if current trends continue. Its increasing mortality is related to a growing number of cases in the setting of non-alcoholic fatty liver disease, the liver manifestation of the metabolic syndrome, and a high proportion of HCC cases being detected at a late stage. While patients detected at an early stage are amenable to curative therapies such as liver transplantation and have a median survival exceeding 5 years, those diagnosed at a late stage traditionally have had limited therapeutic options and a median survival of only 1 year.
Early discovery of liver disease improves chances to cure liver cancer
Liver cancer — the fastest-growing cause of cancer death in the U.S. — has been notoriously difficult to treat.
Similar risk factors observed in lean, non-lean patients with NAFLD
Lean and non-lean patients with nonalcoholic fatty liver disease were similar metabolically and had common risk factors, according to findings published in the Journal of Gastroenterology and Hepatology Open.
Conservative approach may be best treatment in predicted severe acute biliary pancreatitis
Predicted severe acute biliary pancreatitis treated with early endoscopic retrograde cholangiography with sphincterotomy did not reduce major complications or mortality compared with conservative treatment, according to a presenter.
Favorable pregnancy outcomes observed after liver transplant
Severe transplant-related maternal complication and offspring prematurity may occur at a higher proportion after liver transplant vs. the general population, but overall outcomes are positive, researchers reported at UEG Week Virtual.
Larger waistline links to increased liver damage risk in people with type 2 diabetes
Waist circumference independently correlated with the risk for advanced fibrosis among patients with type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes Annual Meeting.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read